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~bstract The dimerization of the FK506-binding peptidyl-pro- 
lyl cisltrans-isomerase (PPIase) FKBP25mem (Mip (macro- 
phage infectivity potentiator) protein) from Legionella pneumo- 
phila was studied by small-angle X-ray solution scattering. A 
~alue of 44 kDa, independent on the protein concentration be- 
lween 2 and 13 mg/ml, confirming that FKBP25mem is a dimer 
was found for the molecular mass of the protein. The radius of 
gyration of the protein is 3.3 nm and the Porod volume 87 nm 3. 
k model of the shape of FKBP25mem was evaluated from the 
~cattering curve. Each monomer consists of a proximal and a 
peripheral domain, which are perpendicular to each other. The 
envelope of the crystallographic model of human FKBP12 fits 
wefi into the peripheral domain. The contact regions between the 
two monomers in the dimeric protein are probably located be- 
tween the N-terminal parts of the monomers. 
Key words': Small-angle X-ray solution scattering; 
FKBP25mem; Legionella pneumophila; Dimer; Peptidyl-prolyl 
:is/trans-Isomerase; Spherical harmonics 
1. Introduction 
The enzyme class of peptidyl-prolyl cis/trans-isomerases 
(PPIases; EC 5.2.1.8) consists presently of four families, the 
cyclophilins (Cyps), FK506-binding proteins (FKBPs), parvul- 
ins, and trigger factors, having only little, if any, sequence 
similarity with each other. They catalyse the cis/trans-isomeri- 
zation of peptidyl-prolyl bonds in oligopeptides and accelerate 
slow rate-limiting steps in the refolding of proteins in vitro and 
in vivo (for a review, see [1,2]). This catalytic activity is inhibited 
by their tight binding to the immunosuppressive drugs cy- 
closporin A or FK506 and rapamycin. Cyclophilins and 
FKBPs occur in mammals as well as plants, fungi and bacteria, 
but until now an PPIase-active member of the parvulin family 
was only found in Escheriehia coli [3,4]. 
Several proteins in different organisms and cell types were 
found to be associated with cyclophilins or FKBPs. The human 
host cell protein cyclophilinl8 binds specifically to a four pro- 
line stretch of the HIV-1 Gag polyprotein and the presence of 
Cypl8 in the virus particle was shown to be essential for the 
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infectivity of the virions [5,6]. Cyclophilins as well as FKBPs 
are assembled into inactive steroid receptor complexes. Human 
FKBP52 and the homologous mouse (p59), rabbit (FKBP59) 
and chicken proteins (hsp56) are immunophilins binding the 
heat-shock proteins hsp90 and hsp70 and are components of 
the unliganded glucocorticoid or progesterone r ceptor com- 
plex [7-12]. PPIase activity inhibited by FK506 in the nmol 
range was determined for FKBP51 purified from Jurkat cells 
[9], for recombinant human FKBP52 [7], and for glutathion-S- 
transferase-fusion proteins of full-length rabbit FKBP59 (HBI) 
and its two N-terminal domains [11]. Intbrmation about the 
enzymatic activity of the proteins within the steroid receptor 
complexes is, however, lacking. Besides their ability to form 
heterooligomeric complexes with heat-shock proteins and ster- 
oid receptors homooligomerization was observed for a 17,000 
fragment, resulting from limited digestion of chicken thymus 
FKBP52, and for the Jurkat cell FKBP51 only in the presence 
of FK506 [9,10]. Radanyi et al. [13] examined rabbit FKBP59- 
HBI in non-denaturating polyacrylamide gel electrophoresis, 
density gradient and gel filtration analysis giving no suggestion 
for homooligomerization f the native protein which is not 
complexed with FK506. In contrast o that we were recently 
able to show that FKBP25mem (Mip protein) from the Gram- 
negative bacterium Legionella pneumophila, the causative agent 
of Legionnaires' disease, is active as a homodimer with the 
monomeric form having little, if any, PPIase activity compared 
to the dimeric enzyme [14]. The protein is located at the outer 
membrane surface of the cells and was shown to be one major 
virulence factor of this organism. FKBP25mem-negative mu- 
tants have reduced ability to survive in their eukaryotic host 
cells, macrophages and monocytes [15,16]. The PPIase activity 
of L. pneumophila FKBP25mem is inhibited by FK506 in the 
nmol range and the substrate specificity profile toward syn- 
thetic peptides is similar to that of human (h) FKBP12 [17]. 
Amino acid sequence analysis of L. pneumophila 
FKBP25mem revealed the existence of two domains in the 
primary structure. The N-terminal sequence (residues 1-106 of 
the mature protein) has no similarity to any known protein 
except Mip homologues. The C-terminal part of the protein 
shows high homology to FKBPs with the conservation of 10/14 
residues of hFKBPI2 located within a 4-/~ surrounding from 
the bound ligand FK506 [18]. 
The 3-D structure of FKBPI2 was extensively studied with 
and without bound ligands in solution and in crystals (for a 
review, see [ 19]). Both the structure determination by N MR and 
X-ray crystallography showed that FKBP12 is composed by a 
five-stranded t-sheet which wraps around a short amphiphilic 
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a-helix. The hydrophobic binding site for FK506 is located 
between the cz-helix and the interior wall of the fl-sheet 
[18,20,21]. According to secondary structure prediction, the 
C-terminal part of FKBP25mem seems to contain the same 
structural properties as hFKBP12. 
In this work, we describe xperiments on the self-association 
behaviour of L. pneumophi la FKBP25mem using small-angle 
X-ray solution scattering. It is shown that over a large range 
of concentrat ion (2-13 mg/ml) the protein exists as a dimer in 
solution. The shape of FKBP25mem evaluated from the scat- 
tering curves using spherical harmonics uggests possible con- 
tact regions between the monomers. 
2. Experimental 
2.1. Protein purification and sample preparation 
The FKBP25mem was purified from the recombinant E. coli strain 
HB101 (pBLL 106) [17] according to Ludwig et al. [22]. The pure 
protein was concentrated and dialysed against 20 mM Hepes/NaOH 
buffer, pH 7.0, using a centricon concentrator 10,000 Da (Amicon). 
Protein concentration was determined spectrophotometrically. Extinc- 
tion coefficients at 280 nm were calculated from amino acid sequence 
according to Gill and von Hippel [23]. As shown by measurements of 
circular dichroism and catalytic activity, the protein was not damaged 
by irradiation during small-angle X-ray solution scattering experi- 
ments. 
PPIase activity was determined using the synthetic peptide Suc-Ala- 
Phe-Pro-Phe-4-nitroanilide as substrate in a 2-step reaction coupled to 
chymotrypsin developed by Fischer et al. [24] using a Hewlett Packard 
8452 diode array UV/VIS spectrophotometer. Secondary structure pre- 
dictions were made using the HIBIO PROSIS version 7.0 software 
(Hitachi Software, Brisbane, USA). 
2.2. X-ray solution scattering 
The data were collected on the X33 camera [25-27] of the EMBL on 
the storage ring DORIS of the Deutsches Elektronen Synchrotron 
(DESY) using multiwire proportional chambers with delay line readout 
[28]. Data were collected at two different camera lengths covering 
ranges of momentum transfer s = 41rsin0/2 (20 is the scattering angle 
and 2 the wavelength) between 0.15 < s < 1.8 nm -l and 0.65 < s < 4.0 
nm z For the low-angle measurements, solutions with 2-9 mg/ml were 
used to avoid interparticle interferences whereas for the higher angles 
the concentrations were up to 20 mg/ml. The data were normalized to 
the intensity of the incident beam, corrected for the response of the 
detector, the scattering of the buffer was subtracted and the statistical 
errors were calculated using the program SAPOKO (Svergun and 
Koch, unpubl, data). Data from the two different s-ranges were scaled 
for concentration and merged by equalizing the mean value of the 
scattering in the range 0.65 < s < 1.85 nm -~. 
2.3. Methods of  data analysis 
Preliminary estimate of the maximum particle size was obtained by 
a method based on orthogonal expansion [29]. The experimental data 
were then processed using the indirect transform program package 
GNOM [30 32] to evaluate the particle distance distribution function 
p(r). The shape of the dimeric particle was evaluated by rnultipole 
expansion [33 35]. The 3-D density distribution p(r) of a monomer is 
approximated in spherical coordinates (r, 0, ¢) by an angular boundary 
function F(o)) of co = (0, ~0) such that p(r) = 1 for r < F(co) and p(r) = 0 
for r > F(w). This shape function is developed into a series of spherical 
harmonics YL~ (0, ~p) as: 
L I 
F(w) = Z Y~ fm Film((/)) (1) 
1-0  m- - I  
The angular esolution is ~r/(L + 1 ), and the coefficients fro are complex 
numbers. The scattering intensity of the monomer is then 
L 
Im(S) = 2,~ 2 • Z IAlm(S)l 2 (2) 
I=0  m=-[  
where the partial amplitudes Aim (S) are evaluated from the coefficients 
fm via the power series representation. The amplitudes Aim (S) enable 
to evaluate the scattering from a second monomer obtained by the 
symmetry operation. Assuming for simplicity that the 2-fold axis coin- 
cides with the z-axis, the scattering intensity from the dimer la (s) is the 
function of the fm coefficients of the monomer and the distance X 
between the centres of monomers along the x-axis. These are the un- 
knowns which are evaluated using an adaptive non-linear least-squares 
fit [36] to the processed experimental intensities (Svergun, Barberato, 
Volkov and Koch, in prep.). 
3. Results and discussion 
The experimental data from FKBP25mem were first proc- 
essed with the orthogonal  expansion program to give an esti- 
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Fig. 1. (a) Experimental curve from FKBP25mem (points with error 
bars), processed curve (l), the processed curve after subtracting a con- 
stant and the scattering from the final model (2); (b) distance distribu- 
tion function with error bars. 
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Fig. 2. Model of the dimer of FKBP25mem together with the envelopes 
of human FKBP12 fitted into the peripheral domains. The two-fold axis 
coincides with z-axis, the length of the axes is 2 nm. FKBP25mem is 
displayed as a wireframe and hFKBPI2 as a shaded solid. Fig. b is 
obtained by rotating Fig. a around x-axis clockwise by 90 °. 
mate of the particle maximum diameter D = I 1 nm. Results of 
the data treatment by the indirect program GNOM using this 
maximum diameter are presented in Fig. 1. The p(r) function 
(Fig. lb) is bimodal suggesting that the particle is a dimer and 
this is confirmed by the fact that the normalized forward scat- 
tering of FKBP25mem (molecular mass 22,800) is ~5x that of 
lysozyme (molecular mass 15,000). The particle invariants, ra- 
dius of gyration (R6 = 3.3 nm) and the Porod volume (V = 87 
nm 3) are also consistent with the dimeric form of FKBP25mem 
in solution and indicate that the particle is rather anisometric. 
The molecular mass calculated from the scattering patterns 
of the FKBP25mem is 44,000. It is independent on the protein 
concentration between 2 and 13 mg/ml as indicated by the 
proportional dependence of the extrapolated forward scatter- 
ing (I0) on the protein concentration. This is confirmed by the 
nmol dissociation constant of the dimer determined by kinetic 
measurements published earlier [14]. 
For the shape determination f FKBP25mem, the processed 
curve was normalized to the Porod volume and a constant was 
subtracted to reduce the influence of the intraparticle inhomo- 
geneities and force the s -4 behaviour at large s. The resulting 
curve (Fig. la) was then fitted by the minimization algorithm 
searching for the shape of a monomer and the centre-to-centre 
distance between the two monomers in the dimer. The resulting 
shape of FKBP25mem up to the multipole resolution L = 4 
corresponding to a spatial resolution o f -2  nm is presented in
Fig. 2. Differences between the scattering curve from this model 
and curve 2 in Fig. la are not recognizable in the plot. This 
model is described by (L + 1)2+ 1 = 26 parameters, out of 
which 5 parameters are correlated ue to the rotations and the 
arbitrary displacement of the centre of mass of the monomer 
along the 2-fold axis. This leaves 21 parameters which are still 
not entirely independent because of the condition F(o)) > 0. The 
range of measurements contains (SmaxDmax[N) + 1 = 15 Shan- 
non's channels which gives an estimate of the number of inde- 
pendent parameters in the experimental data set [37,38]. The 
above considerations justify the use of the model up to the 
resolution L = 4 but should not be taken as the suggestion that 
the model is unique. Interpretation of the diffraction data is 
always ambiguous especially as the correlation between the 
observed ata and the model parameters i  non-linear. In fact, 
starting from different initial approximations, several different 
models with L = 4 can be generated which produce practically 
the same scattering curve. They all, however, show similar 
features, namely that the monomer consists of two well-defined 
domains, one proximal and one peripheral, which are perpen- 
dicular to each other. The model in Fig. 2 has been selected to 
give the best visual overlap between the two proximal domains, 
and also the best fit between the shape of the peripheral domain 
and that of hFKBP12. The models at lower resolution (L = 3) 
also provide a reasonable fit to the experimental data up to 
s = 2 nm -~ but fail to follow the trend of the scattering curve 
at higher momentum transfers. The agreement between the 
model (lmoa) and the experimental data (l~xp) measured by the 
R-factor defined as: 
snlax 
I 
0 
R= 
[l~xp(S) Imoa(S) l s2ds 
,~max 
f l~xi,(s)s2ds 
0 
in the range 0 < s < 4 nm -~ is 1.2.10 -2 at L = 3 against 2.1 • 10  -3  
atL=4.  
Primary sequence analysis and secondary structure predic- 
tion according to the algorithm of Chou and Fasman [39] and 
Rose [40] showed that the FKBP25mem consists of two do- 
mains. The C-terminal domain exhibits 35% identity and 55% 
homology, respectively, with the amino acid sequence of 
hFKBP12. According to secondary structure prediction, this 
domain has a globular folding similar to that of hFKBP12, 
including the hydrophobic binding pocket which is also indi- 
cated by the similar substrate specificity profiles of the two 
PPIases measured with synthetic peptides [17,41]. The N-termi- 
nal domain (residues 1-106) shows no homology to any known 
protein and is suggested to contain a long c~-helix, including 
residues 34--70 [14]. The envelope of the atomic model of 
hFKBPI2 evaluated from the Brookhaven PDB coordinates 
[42] differs significantly in shape from the proximal domain of 
the FKBP25mem monomer but can be neatly fitted to the 
elongated peripheral domain (Fig. 2). The chosen orientation 
of the hFKBP12 within the peripheral domain allows the elon- 
gation of the N-terminal part of the amino acid chain into the 
proximal, N-terminal domain of the FKBP25mem. The shape 
model of FKBP25mem dimer gives some ideas for possible 
contact regions between the monomers, confirming that the 
dimerization involves mostly the N-terminal domains, espe- 
cially the long c~-helices, of each monomer, as we suggested 
earlier [14]. Preliminary experiments with the cloned C-terminal 
domain of the FKBP25mem showed that this part of the pro- 
tein alone is inactive as a PPIase, probably due to the stabiliza- 
172 B. Schmidt et al./FEBS Letters 372 (1995) 169 172 
tion of the monomeric state (B. Schmidt, unpubl, data), which 
also supports the model in Fig. 2. 
This model of the shape and the position of the FKBP25mem 
monomers in the dimeric protein provides now a starting point 
for further investigations on the role of this activity-related 
dimerization in mediating virulence of L. pneumophila. 
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